Calgranulins in cystic fluid and serum from patients with ovarian carcinomas.
Helmut W. Ott(University Hospital Innsbruck), Karl Illmensee(Fox Chase Cancer Center), S. Fessler, Peter Schwaerzler, Bettina Sarg, Elisabeth Mueller‐Holzner, A. Bergant(Universität Innsbruck), Alain G. Zeimet(Innsbruck Medical University), Herbert Lindner, Christian Marth(Nordic Society of Gynecologic Oncology), Burkhard Abendstein
PubMed
November 1, 2003
Cited by 79
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
Normal genetically mosaic mice produced from malignant teratocarcinoma cells.
|Proceedings of the National Academy of Sciences|1975|1.2k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
|International Journal of Gynecological Cancer|2015|757
Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts.
|Proceedings of the National Academy of Sciences|1976|469